Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Type 2 Diabetes Mellitus.”

1,703 trials

Showing 20 of 1,703 results

Early research (Phase 1)Study completedNCT02065752
What this trial is testing

A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components

Who this might be right for
Healthy Volunteers
Janssen Research & Development, LLC 2
Large-scale testing (Phase 3)UnknownNCT04667143
What this trial is testing

Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy

Who this might be right for
Diabetes Mellitus, Type II
Jiangsu HengRui Medicine Co., Ltd. 760
Large-scale testing (Phase 3)Study completedNCT01326026
What this trial is testing

Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes Mellitus

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 222
Early research (Phase 1)Study completedNCT01188863
What this trial is testing

Study of Two Oral Formulations of LX4211 in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Lexicon Pharmaceuticals 15
Large-scale testing (Phase 3)Study completedNCT01076647
What this trial is testing

Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 467
Large-scale testing (Phase 3)Study completedNCT04880850
What this trial is testing

A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4)

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 582
Early research (Phase 1)UnknownNCT02467790
What this trial is testing

Polyethylene Glycol Loxenatide Pharmacokinetics Study in Subjects With Normal and Insufficiency Renal Function

Who this might be right for
Type 2 Diabetes Mellitus
Jiangsu Hansoh Pharmaceutical Co., Ltd. 24
Not applicableStudy completedNCT01114438
What this trial is testing

Post Marketing Study in Subjects Who Have Type 2 Diabetes Using the EndoBarrier™ Gastrointestinal Liner

Who this might be right for
Type 2 DiabetesObesity
Morphic Medical Inc. 45
Not applicableStudy completedNCT03733743
What this trial is testing

Day-night Rhythm in Muscle Metabolism of Prediabetics

Who this might be right for
Diabetes Mellitus, Type 2Insulin Resistance
Maastricht University 12
Large-scale testing (Phase 3)WithdrawnNCT02229240
What this trial is testing

Albiglutide Versus Placebo Added-on to Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline
Early research (Phase 1)Study completedNCT00538174
What this trial is testing

Phase I Multiple-Ascending Dose (Japan)

Who this might be right for
Diabetes Mellitus, Type 2
AstraZeneca 36
Post-approval studies (Phase 4)Study completedNCT03066089
What this trial is testing

Clinical Evaluation of Fenfuro (Fenugreek Seed Extract) in Type-2 Diabetic Subjects: an add-on Study

Who this might be right for
Type 2 Diabetes Mellitus
Chemical Resources 104
Early research (Phase 1)Study completedNCT05328726
What this trial is testing

Single, Ascending Dose, First Time in Human Study for GZR18 in Healthy Subjects

Who this might be right for
Diabetes Mellitus, Type 2
Gan and Lee Pharmaceuticals, USA 24
Large-scale testing (Phase 3)WithdrawnNCT02015780
What this trial is testing

Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Disease
Takeda
Early research (Phase 1)Study completedNCT01916174
What this trial is testing

A Trial to Demonstrate Bioequivalence Between Two Insulin Degludec/Liraglutide Formulations, B5 and V2 in Healthy Subjects

Who this might be right for
DiabetesDiabetes Mellitus, Type 2Healthy
Novo Nordisk A/S 50
Not applicableStudy completedNCT00715780
What this trial is testing

Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-diabetic Agents

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 1,667
Large-scale testing (Phase 3)Study completedNCT01467323
What this trial is testing

Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 303
Large-scale testing (Phase 3)WithdrawnNCT04287179
What this trial is testing

SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S
Early research (Phase 1)Study completedNCT04109508
What this trial is testing

A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (C) Semaglutide Tablets

Who this might be right for
Healthy VolunteersType 2 Diabetes
Novo Nordisk A/S 278
Early research (Phase 1)Study completedNCT03310944
What this trial is testing

Comparison of Sotagliflozin Prototype Tablets With Reference Tablet in Healthy Subjects

Who this might be right for
Type 1 Diabetes MellitusType 2 Diabetes Mellitus
Sanofi 12
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation